Trevi Therapeutics, INC. (TRVI) SEC Filings — 2025

Filings

• Trevi Therapeutics, INC. 8-K Filing — 8-K · Dec 5, 2025
• Trevi Narrows Q3 Loss Amid Haduvio Development, Boosts Cash Reserves — 10-Q · Nov 13, 2025
• Trevi Therapeutics Reports Officer and Director Changes — 8-K · Aug 20, 2025
• Trevi Therapeutics Widens Q2 Loss Amid Rising G&A Costs — 10-Q · Aug 7, 2025
• Trevi Therapeutics Files 8-K on Officer/Director Changes — 8-K · Jun 17, 2025
• Trevi Therapeutics Files 8-K: Material Agreement, Other Events — 8-K · Jun 4, 2025
• Trevi Therapeutics Files 8-K for Other Events — 8-K · Jun 2, 2025
• Trevi Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
• Trevi Therapeutics Files DEF 14A on Executive Compensation — DEF 14A · Apr 29, 2025
• Trevi Therapeutics Files 2024 10-K — 10-K · Mar 18, 2025
• Trevi Therapeutics Files 8-K Report — 8-K · Mar 10, 2025
• Trevi Therapeutics Files 8-K on Operations and Financials — 8-K · Jan 8, 2025